Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
Learn more: Charité researchers lay the groundwork for drugs with fewer side effects
The Latest on: Pain medications
[google_news title=”” keyword=”pain medications” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pain medications
- Myalgia (Muscle Pain)on May 9, 2024 at 2:30 pm
Medically reviewed by Stella Bard, MD Myalgia is the medical term for muscle pain. It's a common complaint in people of all ages. Daily life stress or tension to more debilitating health conditions ...
- Cancer patients turn to 'oncology massages' to relieve pain, anxiety, nauseaon May 9, 2024 at 2:27 pm
It's been almost 10 years since a routine screening detected a rare -- and very aggressive -- cancer inside Kathleen Kennedy-Tuttle.
- Best pain relief patches: 6 top choices to reduce inflammationon May 9, 2024 at 1:15 am
Whether it is persistent muscle soreness or joint discomfort, chronic pain can impact your daily life negatively. Try pain relief patches for relaxation. Formulated using ingredients like menthol and ...
- Almost 30% of children and adolescents experience pain in muscles, bones or ligaments, study showson May 8, 2024 at 1:44 pm
Some 27% of Brazilian children and adolescents suffer from musculoskeletal pain of unspecified cause, according to a study reported in the Brazilian Journal of Physical Therapy. The problem is ...
- See The 50 Most Prescribed Drugs In The US Todayon May 8, 2024 at 11:29 am
Millions rely on medication to manage their health. Whether it’s a quick prescription to treat an illness or a long-term medication for a chronic illness, the vast majority of Americans do ...
- How to Stop De Quervain’s Tenosynovitis From Being a Pain in the Wriston May 8, 2024 at 9:02 am
When simple daily tasks cause ongoing pain on the thumb side of your wrist, you may have De Quervain's Tenosynovitis. Although the name sounds complicated, De Quervain's Tenosynovitis is a common and ...
- Postprocedural pain medication receives label expansion from FDAon May 8, 2024 at 6:32 am
Officials with the FDA have modified the label for buprenorphine extended-release injectable suspension (Ethiqa XR; Fidelis Animal Health) 1.3mg/mL with an expansion to include indication for nonhuman ...
- Why trigger points cause so much pain—and how you can relieve iton May 7, 2024 at 5:00 pm
On the DIY end of the spectrum, the application of heat or ice (whichever feels better) or a topical analgesic cream, and use of over-the-counter non-steroidal anti-inflammatory drugs (like ibuprofen ...
- 4 Things You Should Know If You Take NSAIDs for Chronic Back Painon May 7, 2024 at 7:40 am
While it’s definitely okay—and common!—to take NSAIDs for long-term back issues, it’s best to do so armed with knowledge and, in some cases, under the guidance of a doctor. Here’s all the stuff you ...
via Bing News